IIQ Relative Valuation - INOVIQ Ltd

Watchlist Manager

Watchlist

Price: 0.33 AUD Market Closed

Market Cap: AU$46.5m

	INOVIQ Ltd ASX:IIQ	AU
	Larimar Therapeutics Inc NASDAQ:LRMR	US
	Sino Hotels (Holdings) Ltd HKEX:1221	HK
Y	Yoshi Innovation SA WSE:YOS	PL
	Wealthking Investments Ltd HKEX:1140	HK
I	Indian Oil Corporation Ltd BSE:530965	IN
G	Guangdong New Grand Long Packing Co Ltd SZSE:002836	CN
	Ostin Technology Group Co Ltd NASDAQ:OST	CN
M	Majuba Hill Copper Corp CNSX:JUBA	CA

Relative Value

The Relative Value of one IIQ stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.33 AUD, INOVIQ Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Relative Value calculated?

IIQ Relative Value

Show

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
AU		INOVIQ Ltd ASX:IIQ	46.5m AUD	50.7	-6.4	-4.5	-4.5
US		CVS Health Corp NYSE:CVS	92.5B USD	0.2	52.3	13.6	13.6
US	C	Cigna Group XMUN:CGN	66.7B EUR	0.3	12.9	7.6	9.7
US		Cigna Corp NYSE:CI	70B USD	0.3	11.8	0	0
DE		Fresenius SE & Co KGaA XETRA:FRE	24.8B EUR	1.1	19.6	9.3	13.9
DE		Fresenius Medical Care AG XMUN:FME	21.7B EUR	1.1	22.8	8.8	16.3
US		Laboratory Corporation of America Holdings NYSE:LH	21.9B USD	1.6	24.9	12	17.4
US		Quest Diagnostics Inc NYSE:DGX	21.6B USD	2	21.8	11.8	15.9
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.5B EUR	0.5	10.8	5.3	9.7
US		Guardant Health Inc NASDAQ:GH	10.9B USD	11.1	-26.2	-28.7	-26.1
US		DaVita Inc NYSE:DVA	10.5B USD	0.8	14.1	7.2	9.8

				Revenue Growth	P/S to Growth
AU		INOVIQ Ltd ASX:IIQ	Average P/S: 6.3 50.7	80%	0.6
US		CVS Health Corp NYSE:CVS	0.2	4%	0.1
US	C	Cigna Group XMUN:CGN	0.3	6%	0
US		Cigna Corp NYSE:CI	0.3	6%	0
DE		Fresenius SE & Co KGaA XETRA:FRE	1.1	5%	0.2
DE		Fresenius Medical Care AG XMUN:FME	1.1	3%	0.4
US		Laboratory Corporation of America Holdings NYSE:LH	1.6	6%	0.3
US		Quest Diagnostics Inc NYSE:DGX	2	5%	0.4
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	0.5	3%	0.2
US		Guardant Health Inc NASDAQ:GH	11.1	29%	0.4
US		DaVita Inc NYSE:DVA	0.8	4%	0.2

				Earnings Growth	PEG
AU		INOVIQ Ltd ASX:IIQ	Average P/E: 21.2 Negative Multiple: -6.4	N/A	N/A
US		CVS Health Corp NYSE:CVS	52.3	90%	0.6
US	C	Cigna Group XMUN:CGN	12.9	19%	0.7
US		Cigna Corp NYSE:CI	11.8	19%	0.6
DE		Fresenius SE & Co KGaA XETRA:FRE	19.6	26%	0.8
DE		Fresenius Medical Care AG XMUN:FME	22.8	16%	1.4
US		Laboratory Corporation of America Holdings NYSE:LH	24.9	27%	0.9
US		Quest Diagnostics Inc NYSE:DGX	21.8	12%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	10.8	16%	0.7
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -26.2	N/A	N/A
US		DaVita Inc NYSE:DVA	14.1	20%	0.7

				EBITDA Growth	EV/EBITDA to Growth
AU		INOVIQ Ltd ASX:IIQ	Average EV/EBITDA: 9.5 Negative Multiple: -4.5	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.6	28%	0.5
US	C	Cigna Group XMUN:CGN	7.6	4%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	9.3	10%	0.9
DE		Fresenius Medical Care AG XMUN:FME	8.8	7%	1.3
US		Laboratory Corporation of America Holdings NYSE:LH	12	10%	1.2
US		Quest Diagnostics Inc NYSE:DGX	11.8	6%	2
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	5.3	7%	0.8
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -28.7	N/A	N/A
US		DaVita Inc NYSE:DVA	7.2	4%	1.8

				EBIT Growth	EV/EBIT to Growth
AU		INOVIQ Ltd ASX:IIQ	Average EV/EBIT: 13.3 Negative Multiple: -4.5	N/A	N/A
US		CVS Health Corp NYSE:CVS	13.6	22%	0.6
US	C	Cigna Group XMUN:CGN	9.7	5%	1.9
US		Cigna Corp NYSE:CI	Not Available	N/A	N/A
DE		Fresenius SE & Co KGaA XETRA:FRE	13.9	12%	1.2
DE		Fresenius Medical Care AG XMUN:FME	16.3	11%	1.5
US		Laboratory Corporation of America Holdings NYSE:LH	17.4	18%	1
US		Quest Diagnostics Inc NYSE:DGX	15.9	9%	1.8
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	9.7	11%	0.9
US		Guardant Health Inc NASDAQ:GH	Negative Multiple: -26.1	N/A	N/A
US		DaVita Inc NYSE:DVA	9.8	5%	2

INOVIQ Ltd
ASX:IIQ

Relative Value

Valuation Multiples

Multiples Across Competitors

IIQ Competitors Multiples
INOVIQ Ltd Competitors

See Also

Company

Help

Tools

Stocks

INOVIQ Ltd ASX:IIQ

Relative Value

Valuation Multiples

Multiples Across Competitors

IIQ Competitors Multiples INOVIQ Ltd Competitors

See Also

Company

Help

Tools

Stocks

INOVIQ Ltd
ASX:IIQ

IIQ Competitors Multiples
INOVIQ Ltd Competitors